Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model

Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model

Over expression of the epidermal growth factor receptor (EGFR) in many human epithelial tumors has been correlated with disease progression and poor prognosis. EGFR-inhibiting immunotherapy has already been introduced in cancer therapy. Peptide displaying phage particles in eukaryotic hosts can beh...

Full description

Bibliographic Details
Main Authors: Majid Asadi-Ghalehni, Mohamad Javad Rasaee, Nabiollah Namvar Asl, Masood Khosravani, Masoumeh Rajabibazl, Saeed khalili, Helmout Modjtahedi, Esmaeil Sadroddiny
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-06-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Cancer
Epidermal growth factor receptor
Immunotherapy
Peptide vaccine
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1516

Internet

https://ijaai.tums.ac.ir/index.php/ijaai/article/view/1516

Similar Items